logo
Plus   Neg
Share
Email

DuPont Cuts H1, 2013 Operating EPS View - Quick Facts

Chemicals giant EI DuPont De Nemours & Co. (DD), at the Deutsche Bank Global Industrial and Basic Materials conference today, said it aims to generate superior shareholder returns and enhance the company value by aggressively advancing its three strategic priorities such as extending its leadership in high-value, science-driven segments of the agriculture-to-food value chains; strengthening and growing DuPont's position as a provider of differentiated, high-value advanced materials, and; developing industrial biotechnology capabilities that create transformational, new bio-based businesses.

The company said it is on track with its three operational priorities like increasing return on innovation, expanding its global reach and continuing to deliver significant productivity gains. "Unseasonably cool, wet weather across North America and Europe is impacting our Agriculture and Nutrition & Health segments' second-quarter revenues and costs," the firm added.

Therefore, DuPont sees first-half operating earnings per share to be about 10 percent below last year versus the 7-9 percent lower year-on-year outlook communicated earlier. Looking ahead to the second quarter, operating earnings per share is anticipated to be $1.27, while 21 analysts estimate earnings of $1.36 per share.

For the full year 2013, DuPont now projects operating earnings per share to be at the low end of its prior target range of $3.85 - $4.05 per share, based on anticipated improvement in global industrial market demand. On average, 24 analysts polled by Thomson Reuters expect earnings per share of $3.90 for 2013. Analysts' estimates typically exclude one-time items.

The company would announce its second-quarter results on July 23.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>